Page 1 of 1INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.1. Company Name and Address4. EPA ProductRegistrationOMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460DATA CALL-IN RESPONSE3. Date and Type of DCI and NumberGENERIC13-May-2010ID # GDCI-099901-297072. Case # and Name2475 OcthilinoneChemical # and Name099901Octhilinone5. I wish tocancel thisproduct registration voluntarily6. Generic Data7. Product Specific Data7a. My product is an MUP andI agree to satisfy the MUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."7b. My product is an EUP andI agree to satisfy the EUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."6a. I am claiming a GenericData Exemption because Iobtain the active ingredientfrom the source EPA registration number listed below.6b. I agree to satisfy GenericData requirements as indicatedon the attached form entitled"Requirements Status andRegistrant's Response."N.A.N.A.N.A.N.A.N.A.N.A.10. Name of Company11. Phone Number9. Date8. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.Signature and Title of Company's Authorized Representative__________________________________OcthilinoneINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 1 of 3OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #GENERIC13-May-2010GDCI-099901-297072. Case # and Name2475 Octhilinone099901Chemical # and Name8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321Applicator Exposure Data Requirements (Antimicrobial)(29 ,30 ,31)875.110024BB, Y, X, ZDermal exposure--outdoor(15 ,16 ,17)875.120024BB, Y, X, ZDermal exposure--Indoor(12 ,13 ,14)875.130024BB, Y, X, ZInhalation exposure--outdoor(18 ,19 ,20,21)875.140024BB, Y, X, ZInhalation exposure--indoor(1 ,22)875.160024BB, Y, X, ZApplication exposure monitoring data reporting(28)875.170024BB, Y, X, ZProduct Use InformationPost-Application Exposure Data Requirements (ConventionalChemical)(24 ,25 ,26,27)875.250024BB, Y, X, ZInhalation exposurePostapplication Exposure Data Requirements (Antimicrobial)(23)875.280024BB, Y, X, ZDescription of human activity(32 ,33 ,34)875.230024BB, Y, X, ZIndoor surface residue dissipation12. Name of Company13. Phone NumberSignature and Title of Company's Authorized Representative__________________________________10. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. Iacknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law11. DateOcthilinoneINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 2 of 3OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #GENERIC13-May-2010GDCI-099901-297072. Case # and Name2475 Octhilinone099901Chemical # and Name8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(35)875.270024BB, Y, X, ZProduct Use InformationResidue Chemistry Data Requirements (Antimicrobial)(36)860.150024TEPBB, Y, X, ZCrop field trials(HONEY)(37)860.150024TEPBB, Y, X, ZCrop field trials(HONEYCOMB)Toxicology Data Requirements (Antimicrobial)(11)870.346524TGAIBB, Y, X, Z90-day inhalation toxicity(4)850.303012BB, Y, X, ZHoney bee toxicity of residues on foliage(9)850.422512BB, Y, X, ZSeedling emergence, Tier II(10)850.425012BB, Y, X, ZVegetative vigor, Tier II(3 ,7 ,8)850.540012BB, Y, X, ZAlgal toxicity, Tiers 1 and II(5 ,6)870.320024BB, Y, X, Z21/28-day dermal toxicityInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateOcthilinoneINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 3 of 3OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #GENERIC13-May-2010GDCI-099901-297072. Case # and Name2475 Octhilinone099901Chemical # and Name8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(2)SS-WoodLeach24BB, Y, X, ZWood leaching studyInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateCase # and Name:2475 OcthilinoneDCI Number:GDCI-099901-29707Page 1 of 5[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTEP = Typical End Use Product [TEP]; TGAI = Technical Grade Active Ingredient [TGAI]Use Categories Key:X -Y -Z -Materials preservativesIndustrial processes and watersIndustrial processes and watersBB - Wood preservatives1This guideline is required for both dermal and inhalation exposure where applicable.2Protocols must be submitted to the Agency for approval before initiating a study.3Studies needed for 4 organisms: Freshwater Diatom, Marine Diatom, Blue-Green Cyanobacteria, and Freshwater Floating MacrophyteDuckweed.4Data are required only when the formulation contains one or more active ingredients having an acute LD50 of <11 micrograms perbee as determined in the honey bee acute contact study andthe use pattern(s) indicate(s) that honey bees may be exposed to the pesticide.5Required for agricultural uses or if repeated human dermal exposure may occur. Not required if an acceptable 90?day dermal toxicity study is performed and submitted.6EP testing is required if the product, or any component of it, may increase dermal absorption of the active ingredient(s) as determined by testing using the TGAI, or increase toxic orpharmacologic effects.7Not required for aquatic residential uses.8Not required for known phytotoxicants.9Please note that the OPPIN system for generating the Data Call-Ins has not incorporated changes made to 40 CFR Part 158 (revised as of July 1, 2009). The revisions that were made to 40CFR Part 158 for this study titled "seedling emergence" replaced the guideline number 850.4225 4250 with guideline number 850.4100. However, the 850.4100 number can refer to either (orboth) a Tier I or a Tier II study. For the purpose of this DCI, the study requested is for a Tier II study. For more information, see: 158.660 in the current 40 CFR.10Please note that the OPPIN system for generating the Data Call-Ins has not incorporated changes made to 40 CFR Part 158 (revised as of July 1, 2009). The revisions that were made to 40CFR Part 158 for this study titled "vegetative vigor" replaced the guideline number 850.4250 with guideline number 850.4150. However, the 850.4150 number can refer to either (or both) a Tier Ior a Tier II study. For the purpose of this DCI, the study requested is for a Tier II study. For more information, see: 158.660 in the current 40 CFR.11Required if the active ingredient is a gas at room temperature or if the Agency determines that use of the product may result in repeated inhalation exposure at a concentration likely to be toxicregardless of whether the major route of exposure is inhalation.Case # and Name:2475 OcthilinoneDCI Number:GDCI-099901-29707Page 2 of 5[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTEP = Typical End Use Product [TEP]; TGAI = Technical Grade Active Ingredient [TGAI]Use Categories Key:X -Y -Z -Materials preservativesIndustrial processes and watersIndustrial processes and watersBB - Wood preservatives12The Agency will require application exposure data beyond the required product use information (Guideline 875.1700) if at leastone of the following exposure criteria and at least one of thefollowing toxicity criteria are met by the TEP, TGAI, or one of the pesticide's metabolites: (i) Exposure criteria. (A) Dermalexposure is likely to occur during use. (B) Inhalation exposure is likelyto occur during use. (C) Adequate surrogate exposure data (e.g. PHED) to estimate the magnitude of exposure for a particular work activity with an acceptable degree of confidence areunavailable. (ii) Toxicity criteria. (A) The acute dermal LD50 is less than or equal to 200 mg/kg (i.e., Toxicity CategoryI (Guideline 870.1200) as per 40 CFR 156.10). (B) The acute inhalationLC50 (Guideline 870.1300) is less than or equal to 0.05 mg/liter (i.e., 4-hour exposure, Toxicity Category I) and the TGAI hasa vapor pressure greater than 10-3 mm Hg at 25degrees C if usedoutdoors or any indoor application regardless of the vapor pressure. (C) The pesticide is found to be a neurotoxicant (Guideline 870.6200). (D) The pesticide is found to be a developmentaltoxicant (Guidelines 870.3700 and 870.6300). (E) The pesticide is found to be a carcinogen (Guideline 870.4200). (F) The pesticide shows potential adverse effects in subchronic studies suchas 90-day oral (Guideline 870.3100), 21-day repeated dermal toxicity (Guideline 870.3200), 90-day dermal toxicity (Guideline 870.3250), 90-day inhalation (Guideline 870.3465), reproductionand fertility effects (Guideline 870.3800), and chronic feeding (Guideline 870.4100). (G) The pesticide is found to be a mutagen (Guidelines 870.5100 to 870.5900) or an immunotoxicant(Guideline 870.7800). (H) Epidemiological or poisoning incidence data indicate adverse effects from handling the pesticide.13Required for outdoor uses when that is the primary use or if outdoor uses are expected to result in greater exposure than indoor uses.14Protocols must be submitted to the Agency for approval before initiating a study.15The Agency will require application exposure data beyond the required product use information (Guideline 875.1700) if at leastone of the following exposure criteria and at least one of thefollowing toxicity criteria are met by the TEP, TGAI, or one of the pesticide's metabolites: (i) Exposure criteria. (A) Dermalexposure is likely to occur during use. (B) Inhalation exposure is likelyto occur during use. (C) Adequate surrogate exposure data (e.g. PHED) to estimate the magnitude of exposure for a particular work activity with an acceptable degree of confidence areunavailable. (ii) Toxicity criteria. (A) The acute dermal LD50 is less than or equal to 200 mg/kg (i.e., Toxicity CategoryI (Guideline 870.1200) as per 40 CFR 156.10). (B) The acute inhalationLC50 (Guideline 870.1300) is less than or equal to 0.05 mg/liter (i.e., 4-hour exposure, Toxicity Category I) and the TGAI hasa vapor pressure greater than 10-3 mm Hg at 25degrees C if usedoutdoors or any indoor application regardless of the vapor pressure. (C) The pesticide is found to be a neurotoxicant (Guideline 870.6200). (D) The pesticide is found to be a developmentaltoxicant (Guidelines 870.3700 and 870.6300). (E) The pesticide is found to be a carcinogen (Guideline 870.4200). (F) The pesticide shows potential adverse effects in subchronic studies suchas 90-day oral (Guideline 870.3100), 21-day repeated dermal toxicity (Guideline 870.3200), 90-day dermal toxicity (Guideline 870.3250), 90-day inhalation (Guideline 870.3465), reproductionand fertility effects (Guideline 870.3800), and chronic feeding (Guideline 870.4100). (G) The pesticide is found to be a mutagen (Guidelines 870.5100 to 870.5900) or an immunotoxicant(Guideline 870.7800). (H) Epidemiological or poisoning incidence data indicate adverse effects from handling the pesticide.16Protocols must be submitted to the Agency for approval before initiating a study.17Required for indoor uses such as aquaria when the Agency determines such uses are likely to result in greater exposure than outdoor uses.Case # and Name:2475 OcthilinoneDCI Number:GDCI-099901-29707Page 3 of 5[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTEP = Typical End Use Product [TEP]; TGAI = Technical Grade Active Ingredient [TGAI]Use Categories Key:X -Y -Z -Materials preservativesIndustrial processes and watersIndustrial processes and watersBB - Wood preservatives18The Agency will require application exposure data beyond the required product use information (Guideline 875.1700) if at leastone of the following exposure criteria and at least one of thefollowing toxicity criteria are met by the TEP, TGAI, or one of the pesticide's metabolites: (i) Exposure criteria. (A) Dermalexposure is likely to occur during use. (B) Inhalation exposure is likelyto occur during use. (C) Adequate surrogate exposure data (e.g. PHED) to estimate the magnitude of exposure for a particular work activity with an acceptable degree of confidence areunavailable. (ii) Toxicity criteria. (A) The acute dermal LD50 is less than or equal to 200 mg/kg (i.e., Toxicity CategoryI (Guideline 870.1200) as per 40 CFR 156.10). (B) The acute inhalationLC50 (Guideline 870.1300) is less than or equal to 0.05 mg/liter (i.e., 4-hour exposure, Toxicity Category I) and the TGAI hasa vapor pressure greater than 10-3 mm Hg at 25degrees C if usedoutdoors or any indoor application regardless of the vapor pressure. (C) The pesticide is found to be a neurotoxicant (Guideline 870.6200). (D) The pesticide is found to be a developmentaltoxicant (Guidelines 870.3700 and 870.6300). (E) The pesticide is found to be a carcinogen (Guideline 870.4200). (F) The pesticide shows potential adverse effects in subchronic studies suchas 90-day oral (Guideline 870.3100), 21-day repeated dermal toxicity (Guideline 870.3200), 90-day dermal toxicity (Guideline 870.3250), 90-day inhalation (Guideline 870.3465), reproductionand fertility effects (Guideline 870.3800), and chronic feeding (Guideline 870.4100). (G) The pesticide is found to be a mutagen (Guidelines 870.5100 to 870.5900) or an immunotoxicant(Guideline 870.7800). (H) Epidemiological or poisoning incidence data indicate adverse effects from handling the pesticide.19Required for outdoor uses when that is the primary use or if outdoor uses are expected to result in greater exposure than indoor uses.20Protocols must be submitted to the Agency for approval before initiating a study.21Required for indoor uses such as aquaria when the Agency determines such uses are likely to result in greater exposure than outdoor uses.22Data reporting and calculations are required when exposure data are submitted.23The required description of human activity data include data such as frequency and duration of exposure to evaluate the potential differences in exposures of different subpopulations (e.g. adultsand children), and to determine how specific postapplication activity patterns affect exposure levels.24The Agency will require postapplication exposure data beyond the required product use and human activity information by the appropriate route(s) of exposure if at least one of the followingexposure criteria and one of the following toxicity criteria are met by the TGAI or any of the pesticide's metabolites:(i) Exposure criteria. (A) Dermal exposure to workers upon reentry, or tobystanders and residents, is likely to occur. (B) Inhalation exposure to workers upon reentry, or to bystanders and residents,is likely to occur. (C) The human activities associated with thepesticide use pattern (e.g. use in swimming pools and spas) can lead to potentially high exposures. (D) Surrogate exposure data that the Agency deems acceptable (e.g. PHED) to estimatethe magnitude of exposure for a particular postapplication work activity, with an adequate degree of confidence, are unavailable.(ii) Toxicity criteria. (A) The acute dermal LD50 of the TGAI(Guideline 870.1200) is less than or equal to 2000 mg/kg (i.e., Toxicity Category I or II as per 40 CFR 156.10). (B) The acuteinhalation LC50 of the TGAI (Guideline 870.1300) is less than orequal to 0.5 mg/liter (i.e., 4-hour exposure, Toxicity Category I or II) and the TGAI has a vapor pressure greater than 10-3 mmHg at 25 degrees C if used outdoors or any indoor applicationregardless of the vapor pressure. (C) The acute oral LD50 of the TGAI (Guideline 870.1100) is less than 50 mg/kg (i.e., Toxicity Category I). (D) The pesticide is found to be a neurotoxicant(Guideline 870.6200). (E) The pesticide is found to be a developmental toxicant (Guidelines 870.3700 and 870.6300). (F) Thepesticide is found to be a carcinogen (Guideline 870.4200). (G)The pesticide shows potential adverse effects in subchronic studies such as the 90-day oral (Guideline 870.3100), 21-day repeated dose dermal toxicity (Guideline 870.3200), 90-day dermaltoxicity (Guideline 870.3250), 90-day inhalation (Guideline 870.3465), reproduction a25Protocols must be submitted to the Agency for approval before initiating a study.Case # and Name:2475 OcthilinoneDCI Number:GDCI-099901-29707Page 4 of 5[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTEP = Typical End Use Product [TEP]; TGAI = Technical Grade Active Ingredient [TGAI]Use Categories Key:X -Y -Z -Materials preservativesIndustrial processes and watersIndustrial processes and watersBB - Wood preservatives26For antifoulants, testing for postapplication exposure is required to evaluate exposure to persons removing antifoulants from treated surfaces, such as boat hulls, if the activity is not subject toOSHA regulations, and to evaluate bystander inhalation and dermal exposure following application of antifoulants.27In the aquatic areas use category, conditionally required for indoor aquaria or ornamental ponds only.28Use information pertains to the methods of mixing, loading and applying the pesticide and associated work practices that will play an integral part in determining exposure to antimicrobialpesticide handlers. Required product use information includes range and typical values for: Application rates; area treated per day and per year; timing and number of treatments per day andper year for private and professional handlers; exposure time per activity; types of handling equipment; type of clothing worn;geographical distribution of use; and other relevant use data.29The Agency will require application exposure data beyond the required product use information (Guideline 875.1700) if at leastone of the following exposure criteria and at least one of thefollowing toxicity criteria are met by the TEP, TGAI, or one of the pesticide's metabolites: (i) Exposure criteria. (A) Dermalexposure is likely to occur during use. (B) Inhalation exposure is likelyto occur during use. (C) Adequate surrogate exposure data (e.g. PHED) to estimate the magnitude of exposure for a particular work activity with an acceptable degree of confidence areunavailable. (ii) Toxicity criteria. (A) The acute dermal LD50 is less than or equal to 200 mg/kg (i.e., Toxicity CategoryI (Guideline 870.1200) as per 40 CFR 156.10). (B) The acute inhalationLC50 (Guideline 870.1300) is less than or equal to 0.05 mg/liter (i.e., 4-hour exposure, Toxicity Category I) and the TGAI hasa vapor pressure greater than 10-3 mm Hg at 25degrees C if usedoutdoors or any indoor application regardless of the vapor pressure. (C) The pesticide is found to be a neurotoxicant (Guideline 870.6200). (D) The pesticide is found to be a developmentaltoxicant (Guidelines 870.3700 and 870.6300). (E) The pesticide is found to be a carcinogen (Guideline 870.4200). (F) The pesticide shows potential adverse effects in subchronic studies suchas 90-day oral (Guideline 870.3100), 21-day repeated dermal toxicity (Guideline 870.3200), 90-day dermal toxicity (Guideline 870.3250), 90-day inhalation (Guideline 870.3465), reproductionand fertility effects (Guideline 870.3800), and chronic feeding (Guideline 870.4100). (G) The pesticide is found to be a mutagen (Guidelines 870.5100 to 870.5900) or an immunotoxicant(Guideline 870.7800). (H) Epidemiological or poisoning incidence data indicate adverse effects from handling the pesticide.30Required for outdoor uses when that is the primary use or if outdoor uses are expected to result in greater exposure than indoor uses.31Protocols must be submitted to the Agency for approval before initiating a study.32The Agency will require postapplication exposure data beyond the required product use and human activity information by the appropriate route(s) of exposure if at least one of the followingexposure criteria and one of the following toxicity criteria are met by the TGAI or any of the pesticide's metabolites:(i) Exposure criteria. (A) Dermal exposure to workers upon reentry, or tobystanders and residents, is likely to occur. (B) Inhalation exposure to workers upon reentry, or to bystanders and residents,is likely to occur. (C) The human activities associated with thepesticide use pattern (e.g. use in swimming pools and spas) can lead to potentially high exposures. (D) Surrogate exposure data that the Agency deems acceptable (e.g. PHED) to estimatethe magnitude of exposure for a particular postapplication work activity, with an adequate degree of confidence, are unavailable.(ii) Toxicity criteria. (A) The acute dermal LD50 of the TGAI(Guideline 870.1200) is less than or equal to 2000 mg/kg (i.e., Toxicity Category I or II as per 40 CFR 156.10). (B) The acuteinhalation LC50 of the TGAI (Guideline 870.1300) is less than orequal to 0.5 mg/liter (i.e., 4-hour exposure, Toxicity Category I or II) and the TGAI has a vapor pressure greater than 10-3 mmHg at 25 degrees C if used outdoors or any indoor applicationregardless of the vapor pressure. (C) The acute oral LD50 of the TGAI (Guideline 870.1100) is less than 50 mg/kg (i.e., Toxicity Category I). (D) The pesticide is found to be a neurotoxicant(Guideline 870.6200). (E) The pesticide is found to be a developmental toxicant (Guidelines 870.3700 and 870.6300). (F) Thepesticide is found to be a carcinogen (Guideline 870.4200). (G)The pesticide shows potential adverse effects in subchronic studies such as the 90-day oral (Guideline 870.3100), 21-day repeated dose dermal toxicity (Guideline 870.3200), 90-day dermaltoxicity (Guideline 870.3250), 90-day inhalation (Guideline 870.3465), reproduction a33Required if the use pattern and formulation types involve significant potential exposure to humans by evaporation of residues from surfaces or contact with residues on treated surfaces.Case # and Name:2475 OcthilinoneDCI Number:GDCI-099901-29707Page 5 of 5[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTEP = Typical End Use Product [TEP]; TGAI = Technical Grade Active Ingredient [TGAI]34Protocols must be submitted to the Agency for approval before initiating a study.35Required product use information includes reapplication rates and frequencies, re-entry intervals, rinsing and other residue removal practices, and any other use data relevant to exposure afterapplication.36Data are required whenever a pesticide is to be used in a food handling or feed handling establishment unless theoretical calculations, radiolabeled laboratory data, the nature of the residuestudy, or other data show that residues will not occur in food.37Data are required whenever a pesticide is to be used in a food handling or feed handling establishment unless theoretical calculations, radiolabeled laboratory data, the nature of the residuestudy, or other data show that residues will not occur in food.United States Environmental ProtectionAgency Washington, D.C. 20460LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICECo. Nr.Company NameAgent ForAddressCity & StateZipCase # and Name:2475,OcthilinoneLONZA INC90 BOROLINE ROADALLENDALENJ074016836ROHM & HAAS CO100 INDEPENDENCE MALL WESTPHILADELPHIAPA191062399707SANITIZED INCPO Box 2211 57 NEW MILFORD TKPE.NEW PRESTONCT0677702113090THOR GMBHTHOR SPECIALTIES INC.56 QUARRY ROADTRUMBULLCT0661167071